Adage Capital Partners Gp, L.L.C. Roivant Sciences Ltd. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,754,735 shares of ROIV stock, worth $67.9 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,754,735
Previous 3,934,752
46.25%
Holding current value
$67.9 Million
Previous $41.6 Million
59.68%
% of portfolio
0.12%
Previous 0.08%
Shares
9 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$778 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$776 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$638 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$492 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$417 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.31B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...